Fig. 1 (IMAGE)

Osaka University

Fig. 1

Caption

Novel CAR T cells and cord blood-derived CAR NK cells for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

When a patient with KG2032-reactive AML undergoes allogeneic hematopoietic stem cell transplantation from a KG2032-unreactive donor, administration of donor T cells or cord blood-derived NK cells transduced with the KG2032-derived CAR will target the patient's AML cells but not the donor-derived normal hematopoietic cells.

Credit

The University of Osaka

Usage Restrictions

Credit must be given to the creator.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.